Literature DB >> 24329854

Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data.

N Palmateer1, S Hutchinson, G McAllister, A Munro, S Cameron, D Goldberg, A Taylor.   

Abstract

Sharing injecting paraphernalia (containers, filters and water) poses a risk of transmitting the hepatitis C virus (HCV). The prevalence of, and risk of HCV from, such behaviour has not been extensively reported in Europe. People who inject drugs (PWID) were recruited in cross-sectional surveys from services providing sterile injecting equipment across Scotland between 2008 and 2010. Participants completed a questionnaire and provided a blood spot for anonymous testing. Logistic regression was used to examine the association between recent HCV infection (anti-HCV negative and HCV-RNA positive) and self-reported measures of injecting equipment sharing in the 6 months preceding interview. Twelve per cent of the sample reported sharing needles/syringes, and 40% reported sharing paraphernalia in the previous 6 months. The adjusted odds ratios (AOR) for sharing needles/syringes (+/- paraphernalia), and sharing only paraphernalia in the last 6 months were 6.7 (95% CI 2.6-17.1) and 3.0 (95% CI 1.2-7.5), respectively. Among those who reported not sharing needles/syringes, sharing containers and filters were both significantly associated with recent HCV infection (AOR 3.1, 95% CI 1.3-7.8 and 3.1, 95% CI 1.3-7.5, respectively); sharing water was not. We present the first study to apply a cross-sectional approach to the analysis of the association between sharing paraphernalia and incident HCV infection and demonstrate consistent results with previous longitudinal studies. The prevalence of paraphernalia sharing in our study population is high, representing significant potential for HCV transmission.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  cross-sectional; hepatitis C; incidence; injecting paraphernalia; needles/syringes

Mesh:

Substances:

Year:  2013        PMID: 24329854     DOI: 10.1111/jvh.12117

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  22 in total

Review 1.  Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors:  Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

2.  Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT).

Authors:  Brian Conway; Dan Smyth; Réjean Thomas; Alex Wong; Giada Sebastiani; Curtis Cooper; Hemant Shah; Ritesh Kumar; Gretty Deutsch; Ted Watson
Journal:  Can Liver J       Date:  2021-11-11

3.  Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.

Authors:  Matthew J Akiyama; Charles M Cleland; John A Lizcano; Peter Cherutich; Ann E Kurth
Journal:  Lancet Infect Dis       Date:  2019-09-17       Impact factor: 25.071

Review 4.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 5.  Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challenges.

Authors:  Nick Scott; Margaret Hellard; Emma Sue McBryde
Journal:  Virulence       Date:  2015-08-25       Impact factor: 5.882

6.  Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics.

Authors:  Jon E Zibbell; Rachel Hart-Malloy; John Barry; Lillian Fan; Colleen Flanigan
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

7.  Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs.

Authors:  Robert Heimer; Mawuena Binka; Stephen Koester; Jean-Paul C Grund; Amisha Patel; Elijah Paintsil; Brett D Lindenbach
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

8.  Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore.

Authors:  Jada Hackman; Oluwaseun Falade-Nwulia; Eshan U Patel; Shruti H Mehta; Gregory D Kirk; Jacquie Astemborski; Stuart C Ray; David L Thomas; Oliver Laeyendecker
Journal:  Infect Genet Evol       Date:  2019-10-24       Impact factor: 3.342

9.  Talking About Hepatitis C: FAQs From Young Adults Who Inject Drugs.

Authors:  Lauren L Knight; Katherine Wagner; Yuridia Leyva; Veronica R Bruce; Kirsten A M White; Yvonne S Talamantes; Brittany Price; Kimberly Page; Martha L Carvour
Journal:  Health Promot Pract       Date:  2018-09-18

10.  Novel Routes of Potential Hepatitis C Virus Transmission among People Who Inject Drugs: Secondary Blood Exposures Related to Injection Drug Use.

Authors:  Jesse L Goldshear; Kelsey A Simpson; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2021-03-26       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.